Category Archives: People

Bread Financial Provides Performance Update for April 2026

COLUMBUS, Ohio, May 15, 2026 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions to millions of U.S. consumers, provided a performance update. The following tables present the Company’s Net principal loss rate and Delinquency rate for the periods indicated:   […]

Haircare Global Industry Almanac 2021-2030: Shampoo, Hair Colorants, Conditioners, Styling Agents, Perms, Relaxers, Salon Hair Care, and Hair Loss Treatments

The global haircare market presents opportunities through diverse channels like e-commerce and hypermarkets, driven by consumer purchasing power recovery and innovations in product segments such as hair colorants and treatments. Understanding competitive dynamics and regional market performance can aid in strategic positioning. Dublin, May 15, 2026 (GLOBE NEWSWIRE) — The “Haircare Global Industry Almanac 2021-2030” […]

North America (NAFTA) Fish & Seafood Industry Guide 2026: Market Value and Volume Forecasts, Leading Company Profiles, Key Financial Metrics and Competitive Dynamics 2021-2030

Key market opportunities in the NAFTA fish & seafood sector include the US’s leading position, offering growth potential due to its large market size, and Mexico’s rapid growth rate, making it an attractive market for expansion. The industry can leverage competitive insights from leading players and future growth forecasts through 2030. Dublin, May 15, 2026 […]

Fish & Seafood Global Industry Guide 2026: Market Value and Volume Forecasts, Leading Company Profiles, Key Financial Metrics and Competitive Dynamics 2021-2030

The global fish & seafood market offers growth opportunities through diverse segments like chilled, frozen, and fresh seafood, with Asia-Pacific leading at 41% market share. Key opportunities include expanding e-commerce channels and targeting emerging markets affected by currency fluctuations. Dublin, May 15, 2026 (GLOBE NEWSWIRE) — The “Fish & Seafood Global Industry Guide 2021-2030” report […]

Cultural Integration Along Guangxi-Vietnam Border: Baise’s Events Build a Bridge for China-Vietnam Neighborly Connectivity

The Publicity Department of Baise City BAISE, China, May 15, 2026 (GLOBE NEWSWIRE) — Baise, Guangxi, located in southern China, shares contiguous mountains and rivers, intertwined cultural heritage and folk customs with Vietnam. It serves as a vital gateway for people-to-people exchanges and friendly neighborhood interactions along the China-Vietnam border. During the 2026 Guangxi March […]

INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform

Boca Raton, FL, May 15, 2026 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing therapies that target innate immune dysfunction, today announced that results from its Phase 2 MINDFuL trial in Alzheimer’s disease have been published in the peer-reviewed journal NPJ Dementia. The study evaluated the safety, biomarker engagement, and clinical […]

CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients

– High CR rates at any time observed in the CIS-containing population with 85.7% and 92.3% in the ITT population and Efficacy Evaluable population, respectively – High-Grade – EFS in the overall intention-to-treat population was 96.0% at 3 months and 89.5% at 6 months – Efficacy was comparable across concurrent and sequential treatment arms and […]

aTyr Pharma Announces First Quarter 2026 Results and Provides Corporate Update

 Company to continue development of efzofitimod in pulmonary sarcoidosis following Type C meeting with the FDA. Company plans to submit an IND in June 2026 for a Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary sarcoidosis with restrictive lung disease utilizing FVC as primary endpoint and KSQ-Lung as key secondary endpoint. On […]

Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results

Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for norovirus infection, began enrollment in prevention and treatment cohorts Highlighted CDI-988’s mechanism of action and clinical advancement at ICAR 2026 Granted FDA Fast Track designation for CDI-988, enabling the potential for an accelerated development pathway […]

UroGen Reports 94.5% Six-Month Duration of Response in Phase 3 UTOPIA Trial, Advancing UGN-103 Toward Potential Approval in Recurrent Low-Grade Intermediate-Risk NMIBC

PRINCETON, N.J., May 15, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotechnology company focused on transforming the treatment of urothelial and specialty cancers, today announced UGN-103 achieved a 94.5% (95% CI: 86.1, 97.9) durability of response (DOR) at six months by Kaplan-Meier estimate, in the ongoing Phase 3 UTOPIA trial of UGN-103 […]